Latest Strategic Appointments News

Green Technology Metals has appointed Altris Engineering to complete the Definitive Feasibility Study for its Seymour Lithium Project in Ontario, advancing towards a mid-2026 Final Investment Decision amid a disciplined cash strategy.

Altamin Limited has appointed GBA Capital as lead manager to place shortfall shares from its recent entitlement offer, offering broker options as part of the arrangement. This move aims to bolster support for its critical minerals projects in Italy while engaging new and existing investors.

Lodestar Minerals has appointed two former heavy rare earths experts from MP Materials and Lynas Rare Earths to spearhead its U.S. downstream magnet and supply chain strategy, following its planned acquisition of the Virgin Mountain project in Arizona.

Energy Transition Minerals has appointed two former Danish diplomats to its Advisory Board, aiming to strengthen its rare earths project in Greenland amid ongoing legal challenges.

Chimeric Therapeutics has progressed its CHM CDH17 and CHM CORE-NK clinical trials with promising safety and efficacy signals, while securing a key manufacturing partnership and appointing a renowned haematologist to its board. However, the company faces a pressing cash runway challenge.

Theta Gold Mines has commenced bulk earthworks at its flagship TGME gold project in South Africa and secured nearly US$40 million in combined equity and debt funding, marking a pivotal step toward production.

Emperor Energy has secured a significant resource upgrade for its Judith Gas Field and raised $3.7 million to progress the Judith-2 appraisal well, targeting commercial gas supply in a tightening East Coast market.

Norfolk Metals has kicked off its maiden drilling campaign at the Carmen Copper Project in Chile, backed by a A$3.5 million capital raise and the strategic appointment of mining veteran David Fowler to its board.

Alligator Energy has commenced construction of its pivotal Samphire Field Recovery Trial, marking a significant shift from exploration to development. The company also bolstered its leadership team to support this growth phase and reported promising exploration results at its Big Lake Uranium Project.

Radiopharm Theranostics has secured FDA approval to initiate a Phase I trial targeting B7H3 and raised A$40 million to accelerate its radiopharmaceutical programs. The company also appointed renowned oncologist Dr Oliver Sartor to its Scientific Advisory Board.

Toubani Resources has made significant strides in advancing its Kobada Gold Project, reporting promising drilling results and securing a substantial A$395 million funding package to support project development.

Bayan Mining and Minerals Limited reports significant progress in its rare earth and gold exploration projects, highlighted by high-grade assay results and strategic land acquisitions in California and Nevada.